IDiyas

For the Inventor, By the Inventor

Westfield, NJ, United States of America

Richard F Shuman

USPTO Granted Patents = 12

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 91(Granted Patents)


Company Filing History:

goldMedal12 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1976-1998

Loading Chart...
12 patents (USPTO):
1. 5777105 - Process for the preparation of imidazolyl macrolide immunosuppressants (1998-07-07),
2. 5693805 - Process to derivatives of piperizinylcamphorsulfonyl oxytocin antagonists (1997-12-02),
3. 5187278 - Trialkylsilyl trifluoromethanesulfonate mediated .alpha.-methylenic (1993-02-16),
4. 5120847 - Process for iodinating or brominating the .alpha.-methylenic carbon of a (1992-06-09),
5. 5091534 - Trialkylsilyl trifluoromethanesulfonate mediated .alpha.-methylenic (1992-02-25),
6. 5039814 - Ortho-lithiation process for the synthesis of 2-substituted (1991-08-13),
7. 4880928 - Process for the preparation of (1989-11-14),
8. 4510083 - Process for preparing polypeptides (1985-04-09),
9. 4216317 - Process for preparing adenine (1980-08-05),
10. 3970693 - Process for preparing indene acetic acids (1976-07-20),
11. 3953490 - Preparation of (3-trifluoromethylphenoxy)(4-chlorophenyl)acetonitrile (1976-04-27),
12. 3944600 - Indenylidene-3-acetic acid process for preparing indene acetic acids (1976-03-16),

Title: The Innovations of Richard F. Shuman

Introduction

Richard F. Shuman is a notable inventor based in Westfield, NJ (US). He has made significant contributions to the field of immunosuppressants and has been awarded a total of 12 patents throughout his career. His work has had a profound impact on medical science, particularly in the development of new therapeutic agents.

Latest Patents

Among his latest patents is a process for the preparation of imidazolyl macrolide immunosuppressants. This innovative method involves reacting a tricyclo-macrolide with an imidazolmethyl trichloroacetimidate in the presence of an acid. The invention also provides a crystalline salt of imidazolmethyloxy-substituted tricyclo-macrolide, along with novel compounds that are useful in this process. Another significant patent focuses on the derivatives of piperizinylcamphorsulfonyl oxytocin antagonists, showcasing his versatility in addressing various medical challenges.

Career Highlights

Richard F. Shuman has built a successful career at Merck & Company, Inc., where he has been instrumental in advancing pharmaceutical research and development. His expertise and innovative thinking have led to breakthroughs that enhance patient care and treatment options.

Collaborations

Throughout his career, Richard has collaborated with esteemed colleagues such as Anthony O. King and Roger J. Tull. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the pursuit of groundbreaking research.

Conclusion

Richard F. Shuman's contributions to the field of immunosuppressants and his impressive portfolio of patents highlight his role as a leading inventor. His work continues to influence the pharmaceutical industry and improve medical treatments for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…